Investigating Neurocognitive Disorders Epidemiology

Recruiting Observational Study
Dementia Cognitive Decline Alzheimer Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
35 and older
Sex
Any
Study type
Observational
Participants needed
990 (estimated)
Sponsor
King Chulalongkorn Memorial Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This is a prospective cohort study with the main purpose of predicting progression neurocognitive disorders in Thai population. The main predictor variables to be evaluated are plasma phosphorylated tau (p-tau) level and cognitive test scores, which will be combined using statistical/computational modeling. Additionally, it seeks to evaluate biomarkers for diagnosing disease pathologies, understan…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
1. Cognitively Healthy Individuals INCLUSION CRITERIA * Demonstrate normal cognitive function within the expected range on objective cognitive tests. * Proficient in speaking and understanding Thai without the need for a translator to participate. EXCLUSION CRITERIA * Significant ne…
Contacts

Poosanu Thanapornsangsuth, M.D.

+66 (0)2 2564000

poosanu.t@chula.ac.th

CONTACT

Thanakit Pongpitakmetha, M.D.

thanakit.p@chula.ac.th

CONTACT